Ignite Creation Date:
2024-05-05 @ 5:36 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00499902
Status:
TERMINATED
Last Update Posted:
2008-04-24
First Post:
2007-07-10
Brief Title:
Phase 2 Proof-of-Concept Study of the Safety and Efficacy of Alfimeprase to Rapidly Open Arteries and Restore Brain Function Following a Stroke
Sponsor:
ARCA Biopharma Inc
Organization:
ARCA Biopharma Inc
Organization Data
Organization:
ARCA Biopharma Inc
Class:
INDUSTRY
Study ID:
HA009
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ARCA Biopharma Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Brian Kersten PhD
Old Organization:
Nuvelo Inc